Global Over-The-Counter (OTC) Drugs Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Over-The-Counter (OTC) Drugs market report explains the definition, types, applications, major countries, and major players of the Over-The-Counter (OTC) Drugs market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Glenmark

    • Teva Pharmaceuticals

    • GSK

    • Sun Pharmaceutical Industries

    • Novartis

    • PGT healthcare

    • Boehringer Ingelheim

    • Takeda

    • Pfizer

    • Innovus Pharmaceuticals

    • Bayer

    • Cipla

    • Sanofi

    By Type:

    • Cold and Flu Products

    • Analgesics

    • Dermatological Products

    • Gastrointestinal Products

    • Vitamin

    • Other

    By End-User:

    • Hospital Pharmacy

    • Retail Pharmacy

    • Online Pharmacy

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Over-The-Counter (OTC) Drugs Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Over-The-Counter (OTC) Drugs Outlook to 2028- Original Forecasts

    • 2.2 Over-The-Counter (OTC) Drugs Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Over-The-Counter (OTC) Drugs Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Over-The-Counter (OTC) Drugs Market- Recent Developments

    • 6.1 Over-The-Counter (OTC) Drugs Market News and Developments

    • 6.2 Over-The-Counter (OTC) Drugs Market Deals Landscape

    7 Over-The-Counter (OTC) Drugs Raw Materials and Cost Structure Analysis

    • 7.1 Over-The-Counter (OTC) Drugs Key Raw Materials

    • 7.2 Over-The-Counter (OTC) Drugs Price Trend of Key Raw Materials

    • 7.3 Over-The-Counter (OTC) Drugs Key Suppliers of Raw Materials

    • 7.4 Over-The-Counter (OTC) Drugs Market Concentration Rate of Raw Materials

    • 7.5 Over-The-Counter (OTC) Drugs Cost Structure Analysis

      • 7.5.1 Over-The-Counter (OTC) Drugs Raw Materials Analysis

      • 7.5.2 Over-The-Counter (OTC) Drugs Labor Cost Analysis

      • 7.5.3 Over-The-Counter (OTC) Drugs Manufacturing Expenses Analysis

    8 Global Over-The-Counter (OTC) Drugs Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Over-The-Counter (OTC) Drugs Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Over-The-Counter (OTC) Drugs Export by Region (Top 10 Countries) (2017-2028)

    9 Global Over-The-Counter (OTC) Drugs Market Outlook by Types and Applications to 2022

    • 9.1 Global Over-The-Counter (OTC) Drugs Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Cold and Flu Products Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Analgesics Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Dermatological Products Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Gastrointestinal Products Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Vitamin Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Other Consumption and Growth Rate (2017-2022)

    • 9.2 Global Over-The-Counter (OTC) Drugs Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Pharmacy Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Retail Pharmacy Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Online Pharmacy Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Over-The-Counter (OTC) Drugs Market Analysis and Outlook till 2022

    • 10.1 Global Over-The-Counter (OTC) Drugs Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Over-The-Counter (OTC) Drugs Consumption (2017-2022)

      • 10.2.2 Canada Over-The-Counter (OTC) Drugs Consumption (2017-2022)

      • 10.2.3 Mexico Over-The-Counter (OTC) Drugs Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Over-The-Counter (OTC) Drugs Consumption (2017-2022)

      • 10.3.2 UK Over-The-Counter (OTC) Drugs Consumption (2017-2022)

      • 10.3.3 Spain Over-The-Counter (OTC) Drugs Consumption (2017-2022)

      • 10.3.4 Belgium Over-The-Counter (OTC) Drugs Consumption (2017-2022)

      • 10.3.5 France Over-The-Counter (OTC) Drugs Consumption (2017-2022)

      • 10.3.6 Italy Over-The-Counter (OTC) Drugs Consumption (2017-2022)

      • 10.3.7 Denmark Over-The-Counter (OTC) Drugs Consumption (2017-2022)

      • 10.3.8 Finland Over-The-Counter (OTC) Drugs Consumption (2017-2022)

      • 10.3.9 Norway Over-The-Counter (OTC) Drugs Consumption (2017-2022)

      • 10.3.10 Sweden Over-The-Counter (OTC) Drugs Consumption (2017-2022)

      • 10.3.11 Poland Over-The-Counter (OTC) Drugs Consumption (2017-2022)

      • 10.3.12 Russia Over-The-Counter (OTC) Drugs Consumption (2017-2022)

      • 10.3.13 Turkey Over-The-Counter (OTC) Drugs Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Over-The-Counter (OTC) Drugs Consumption (2017-2022)

      • 10.4.2 Japan Over-The-Counter (OTC) Drugs Consumption (2017-2022)

      • 10.4.3 India Over-The-Counter (OTC) Drugs Consumption (2017-2022)

      • 10.4.4 South Korea Over-The-Counter (OTC) Drugs Consumption (2017-2022)

      • 10.4.5 Pakistan Over-The-Counter (OTC) Drugs Consumption (2017-2022)

      • 10.4.6 Bangladesh Over-The-Counter (OTC) Drugs Consumption (2017-2022)

      • 10.4.7 Indonesia Over-The-Counter (OTC) Drugs Consumption (2017-2022)

      • 10.4.8 Thailand Over-The-Counter (OTC) Drugs Consumption (2017-2022)

      • 10.4.9 Singapore Over-The-Counter (OTC) Drugs Consumption (2017-2022)

      • 10.4.10 Malaysia Over-The-Counter (OTC) Drugs Consumption (2017-2022)

      • 10.4.11 Philippines Over-The-Counter (OTC) Drugs Consumption (2017-2022)

      • 10.4.12 Vietnam Over-The-Counter (OTC) Drugs Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Over-The-Counter (OTC) Drugs Consumption (2017-2022)

      • 10.5.2 Colombia Over-The-Counter (OTC) Drugs Consumption (2017-2022)

      • 10.5.3 Chile Over-The-Counter (OTC) Drugs Consumption (2017-2022)

      • 10.5.4 Argentina Over-The-Counter (OTC) Drugs Consumption (2017-2022)

      • 10.5.5 Venezuela Over-The-Counter (OTC) Drugs Consumption (2017-2022)

      • 10.5.6 Peru Over-The-Counter (OTC) Drugs Consumption (2017-2022)

      • 10.5.7 Puerto Rico Over-The-Counter (OTC) Drugs Consumption (2017-2022)

      • 10.5.8 Ecuador Over-The-Counter (OTC) Drugs Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Over-The-Counter (OTC) Drugs Consumption (2017-2022)

      • 10.6.2 Kuwait Over-The-Counter (OTC) Drugs Consumption (2017-2022)

      • 10.6.3 Oman Over-The-Counter (OTC) Drugs Consumption (2017-2022)

      • 10.6.4 Qatar Over-The-Counter (OTC) Drugs Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Over-The-Counter (OTC) Drugs Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Over-The-Counter (OTC) Drugs Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Over-The-Counter (OTC) Drugs Consumption (2017-2022)

      • 10.7.2 South Africa Over-The-Counter (OTC) Drugs Consumption (2017-2022)

      • 10.7.3 Egypt Over-The-Counter (OTC) Drugs Consumption (2017-2022)

      • 10.7.4 Algeria Over-The-Counter (OTC) Drugs Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Over-The-Counter (OTC) Drugs Consumption (2017-2022)

      • 10.8.2 New Zealand Over-The-Counter (OTC) Drugs Consumption (2017-2022)

    11 Global Over-The-Counter (OTC) Drugs Competitive Analysis

    • 11.1 Glenmark

      • 11.1.1 Glenmark Company Details

      • 11.1.2 Glenmark Over-The-Counter (OTC) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Glenmark Over-The-Counter (OTC) Drugs Main Business and Markets Served

      • 11.1.4 Glenmark Over-The-Counter (OTC) Drugs Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Teva Pharmaceuticals

      • 11.2.1 Teva Pharmaceuticals Company Details

      • 11.2.2 Teva Pharmaceuticals Over-The-Counter (OTC) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Teva Pharmaceuticals Over-The-Counter (OTC) Drugs Main Business and Markets Served

      • 11.2.4 Teva Pharmaceuticals Over-The-Counter (OTC) Drugs Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 GSK

      • 11.3.1 GSK Company Details

      • 11.3.2 GSK Over-The-Counter (OTC) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 GSK Over-The-Counter (OTC) Drugs Main Business and Markets Served

      • 11.3.4 GSK Over-The-Counter (OTC) Drugs Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Sun Pharmaceutical Industries

      • 11.4.1 Sun Pharmaceutical Industries Company Details

      • 11.4.2 Sun Pharmaceutical Industries Over-The-Counter (OTC) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Sun Pharmaceutical Industries Over-The-Counter (OTC) Drugs Main Business and Markets Served

      • 11.4.4 Sun Pharmaceutical Industries Over-The-Counter (OTC) Drugs Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Novartis

      • 11.5.1 Novartis Company Details

      • 11.5.2 Novartis Over-The-Counter (OTC) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Novartis Over-The-Counter (OTC) Drugs Main Business and Markets Served

      • 11.5.4 Novartis Over-The-Counter (OTC) Drugs Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 PGT healthcare

      • 11.6.1 PGT healthcare Company Details

      • 11.6.2 PGT healthcare Over-The-Counter (OTC) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 PGT healthcare Over-The-Counter (OTC) Drugs Main Business and Markets Served

      • 11.6.4 PGT healthcare Over-The-Counter (OTC) Drugs Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Boehringer Ingelheim

      • 11.7.1 Boehringer Ingelheim Company Details

      • 11.7.2 Boehringer Ingelheim Over-The-Counter (OTC) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Boehringer Ingelheim Over-The-Counter (OTC) Drugs Main Business and Markets Served

      • 11.7.4 Boehringer Ingelheim Over-The-Counter (OTC) Drugs Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Takeda

      • 11.8.1 Takeda Company Details

      • 11.8.2 Takeda Over-The-Counter (OTC) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Takeda Over-The-Counter (OTC) Drugs Main Business and Markets Served

      • 11.8.4 Takeda Over-The-Counter (OTC) Drugs Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Pfizer

      • 11.9.1 Pfizer Company Details

      • 11.9.2 Pfizer Over-The-Counter (OTC) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Pfizer Over-The-Counter (OTC) Drugs Main Business and Markets Served

      • 11.9.4 Pfizer Over-The-Counter (OTC) Drugs Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Innovus Pharmaceuticals

      • 11.10.1 Innovus Pharmaceuticals Company Details

      • 11.10.2 Innovus Pharmaceuticals Over-The-Counter (OTC) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Innovus Pharmaceuticals Over-The-Counter (OTC) Drugs Main Business and Markets Served

      • 11.10.4 Innovus Pharmaceuticals Over-The-Counter (OTC) Drugs Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 Bayer

      • 11.11.1 Bayer Company Details

      • 11.11.2 Bayer Over-The-Counter (OTC) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 Bayer Over-The-Counter (OTC) Drugs Main Business and Markets Served

      • 11.11.4 Bayer Over-The-Counter (OTC) Drugs Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 Cipla

      • 11.12.1 Cipla Company Details

      • 11.12.2 Cipla Over-The-Counter (OTC) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 Cipla Over-The-Counter (OTC) Drugs Main Business and Markets Served

      • 11.12.4 Cipla Over-The-Counter (OTC) Drugs Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    • 11.13 Sanofi

      • 11.13.1 Sanofi Company Details

      • 11.13.2 Sanofi Over-The-Counter (OTC) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.13.3 Sanofi Over-The-Counter (OTC) Drugs Main Business and Markets Served

      • 11.13.4 Sanofi Over-The-Counter (OTC) Drugs Product Portfolio

      • 11.13.5 Recent Research and Development Strategies

    12 Global Over-The-Counter (OTC) Drugs Market Outlook by Types and Applications to 2028

    • 12.1 Global Over-The-Counter (OTC) Drugs Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Cold and Flu Products Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Analgesics Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Dermatological Products Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Gastrointestinal Products Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.5 Global Vitamin Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.6 Global Other Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Over-The-Counter (OTC) Drugs Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Hospital Pharmacy Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Retail Pharmacy Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Online Pharmacy Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Over-The-Counter (OTC) Drugs Market Analysis and Outlook to 2028

    • 13.1 Global Over-The-Counter (OTC) Drugs Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Over-The-Counter (OTC) Drugs Consumption Forecast (2022-2028)

      • 13.2.2 Canada Over-The-Counter (OTC) Drugs Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Over-The-Counter (OTC) Drugs Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Over-The-Counter (OTC) Drugs Consumption Forecast (2022-2028)

      • 13.3.2 UK Over-The-Counter (OTC) Drugs Consumption Forecast (2022-2028)

      • 13.3.3 Spain Over-The-Counter (OTC) Drugs Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Over-The-Counter (OTC) Drugs Consumption Forecast (2022-2028)

      • 13.3.5 France Over-The-Counter (OTC) Drugs Consumption Forecast (2022-2028)

      • 13.3.6 Italy Over-The-Counter (OTC) Drugs Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Over-The-Counter (OTC) Drugs Consumption Forecast (2022-2028)

      • 13.3.8 Finland Over-The-Counter (OTC) Drugs Consumption Forecast (2022-2028)

      • 13.3.9 Norway Over-The-Counter (OTC) Drugs Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Over-The-Counter (OTC) Drugs Consumption Forecast (2022-2028)

      • 13.3.11 Poland Over-The-Counter (OTC) Drugs Consumption Forecast (2022-2028)

      • 13.3.12 Russia Over-The-Counter (OTC) Drugs Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Over-The-Counter (OTC) Drugs Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Over-The-Counter (OTC) Drugs Consumption Forecast (2022-2028)

      • 13.4.2 Japan Over-The-Counter (OTC) Drugs Consumption Forecast (2022-2028)

      • 13.4.3 India Over-The-Counter (OTC) Drugs Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Over-The-Counter (OTC) Drugs Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Over-The-Counter (OTC) Drugs Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Over-The-Counter (OTC) Drugs Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Over-The-Counter (OTC) Drugs Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Over-The-Counter (OTC) Drugs Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Over-The-Counter (OTC) Drugs Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Over-The-Counter (OTC) Drugs Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Over-The-Counter (OTC) Drugs Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Over-The-Counter (OTC) Drugs Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Over-The-Counter (OTC) Drugs Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Over-The-Counter (OTC) Drugs Consumption Forecast (2022-2028)

      • 13.5.3 Chile Over-The-Counter (OTC) Drugs Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Over-The-Counter (OTC) Drugs Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Over-The-Counter (OTC) Drugs Consumption Forecast (2022-2028)

      • 13.5.6 Peru Over-The-Counter (OTC) Drugs Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Over-The-Counter (OTC) Drugs Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Over-The-Counter (OTC) Drugs Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Over-The-Counter (OTC) Drugs Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Over-The-Counter (OTC) Drugs Consumption Forecast (2022-2028)

      • 13.6.3 Oman Over-The-Counter (OTC) Drugs Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Over-The-Counter (OTC) Drugs Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Over-The-Counter (OTC) Drugs Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Over-The-Counter (OTC) Drugs Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Over-The-Counter (OTC) Drugs Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Over-The-Counter (OTC) Drugs Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Over-The-Counter (OTC) Drugs Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Over-The-Counter (OTC) Drugs Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Over-The-Counter (OTC) Drugs Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Over-The-Counter (OTC) Drugs Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Over-The-Counter (OTC) Drugs

    • Figure of Over-The-Counter (OTC) Drugs Picture

    • Table Global Over-The-Counter (OTC) Drugs Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Over-The-Counter (OTC) Drugs Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Cold and Flu Products Consumption and Growth Rate (2017-2022)

    • Figure Global Analgesics Consumption and Growth Rate (2017-2022)

    • Figure Global Dermatological Products Consumption and Growth Rate (2017-2022)

    • Figure Global Gastrointestinal Products Consumption and Growth Rate (2017-2022)

    • Figure Global Vitamin Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Pharmacy Consumption and Growth Rate (2017-2022)

    • Figure Global Retail Pharmacy Consumption and Growth Rate (2017-2022)

    • Figure Global Online Pharmacy Consumption and Growth Rate (2017-2022)

    • Figure Global Over-The-Counter (OTC) Drugs Consumption by Country (2017-2022)

    • Table North America Over-The-Counter (OTC) Drugs Consumption by Country (2017-2022)

    • Figure United States Over-The-Counter (OTC) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Canada Over-The-Counter (OTC) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Mexico Over-The-Counter (OTC) Drugs Consumption and Growth Rate (2017-2022)

    • Table Europe Over-The-Counter (OTC) Drugs Consumption by Country (2017-2022)

    • Figure Germany Over-The-Counter (OTC) Drugs Consumption and Growth Rate (2017-2022)

    • Figure UK Over-The-Counter (OTC) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Spain Over-The-Counter (OTC) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Belgium Over-The-Counter (OTC) Drugs Consumption and Growth Rate (2017-2022)

    • Figure France Over-The-Counter (OTC) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Italy Over-The-Counter (OTC) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Denmark Over-The-Counter (OTC) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Finland Over-The-Counter (OTC) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Norway Over-The-Counter (OTC) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Sweden Over-The-Counter (OTC) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Poland Over-The-Counter (OTC) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Russia Over-The-Counter (OTC) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Turkey Over-The-Counter (OTC) Drugs Consumption and Growth Rate (2017-2022)

    • Table APAC Over-The-Counter (OTC) Drugs Consumption by Country (2017-2022)

    • Figure China Over-The-Counter (OTC) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Japan Over-The-Counter (OTC) Drugs Consumption and Growth Rate (2017-2022)

    • Figure India Over-The-Counter (OTC) Drugs Consumption and Growth Rate (2017-2022)

    • Figure South Korea Over-The-Counter (OTC) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Over-The-Counter (OTC) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Over-The-Counter (OTC) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Over-The-Counter (OTC) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Thailand Over-The-Counter (OTC) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Singapore Over-The-Counter (OTC) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Over-The-Counter (OTC) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Philippines Over-The-Counter (OTC) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Over-The-Counter (OTC) Drugs Consumption and Growth Rate (2017-2022)

    • Table South America Over-The-Counter (OTC) Drugs Consumption by Country (2017-2022)

    • Figure Brazil Over-The-Counter (OTC) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Colombia Over-The-Counter (OTC) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Chile Over-The-Counter (OTC) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Argentina Over-The-Counter (OTC) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Over-The-Counter (OTC) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Peru Over-The-Counter (OTC) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Over-The-Counter (OTC) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Over-The-Counter (OTC) Drugs Consumption and Growth Rate (2017-2022)

    • Table GCC Over-The-Counter (OTC) Drugs Consumption by Country (2017-2022)

    • Figure Bahrain Over-The-Counter (OTC) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Over-The-Counter (OTC) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Oman Over-The-Counter (OTC) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Qatar Over-The-Counter (OTC) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Over-The-Counter (OTC) Drugs Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Over-The-Counter (OTC) Drugs Consumption and Growth Rate (2017-2022)

    • Table Africa Over-The-Counter (OTC) Drugs Consumption by Country (2017-2022)

    • Figure Nigeria Over-The-Counter (OTC) Drugs Consumption and Growth Rate (2017-2022)

    • Figure South Africa Over-The-Counter (OTC) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Egypt Over-The-Counter (OTC) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Algeria Over-The-Counter (OTC) Drugs Consumption and Growth Rate (2017-2022)

    • Table Oceania Over-The-Counter (OTC) Drugs Consumption by Country (2017-2022)

    • Figure Australia Over-The-Counter (OTC) Drugs Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Over-The-Counter (OTC) Drugs Consumption and Growth Rate (2017-2022)

    • Table Glenmark Company Details

    • Table Glenmark Over-The-Counter (OTC) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Glenmark Over-The-Counter (OTC) Drugs Main Business and Markets Served

    • Table Glenmark Over-The-Counter (OTC) Drugs Product Portfolio

    • Table Teva Pharmaceuticals Company Details

    • Table Teva Pharmaceuticals Over-The-Counter (OTC) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Pharmaceuticals Over-The-Counter (OTC) Drugs Main Business and Markets Served

    • Table Teva Pharmaceuticals Over-The-Counter (OTC) Drugs Product Portfolio

    • Table GSK Company Details

    • Table GSK Over-The-Counter (OTC) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table GSK Over-The-Counter (OTC) Drugs Main Business and Markets Served

    • Table GSK Over-The-Counter (OTC) Drugs Product Portfolio

    • Table Sun Pharmaceutical Industries Company Details

    • Table Sun Pharmaceutical Industries Over-The-Counter (OTC) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sun Pharmaceutical Industries Over-The-Counter (OTC) Drugs Main Business and Markets Served

    • Table Sun Pharmaceutical Industries Over-The-Counter (OTC) Drugs Product Portfolio

    • Table Novartis Company Details

    • Table Novartis Over-The-Counter (OTC) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Over-The-Counter (OTC) Drugs Main Business and Markets Served

    • Table Novartis Over-The-Counter (OTC) Drugs Product Portfolio

    • Table PGT healthcare Company Details

    • Table PGT healthcare Over-The-Counter (OTC) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table PGT healthcare Over-The-Counter (OTC) Drugs Main Business and Markets Served

    • Table PGT healthcare Over-The-Counter (OTC) Drugs Product Portfolio

    • Table Boehringer Ingelheim Company Details

    • Table Boehringer Ingelheim Over-The-Counter (OTC) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boehringer Ingelheim Over-The-Counter (OTC) Drugs Main Business and Markets Served

    • Table Boehringer Ingelheim Over-The-Counter (OTC) Drugs Product Portfolio

    • Table Takeda Company Details

    • Table Takeda Over-The-Counter (OTC) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Takeda Over-The-Counter (OTC) Drugs Main Business and Markets Served

    • Table Takeda Over-The-Counter (OTC) Drugs Product Portfolio

    • Table Pfizer Company Details

    • Table Pfizer Over-The-Counter (OTC) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Over-The-Counter (OTC) Drugs Main Business and Markets Served

    • Table Pfizer Over-The-Counter (OTC) Drugs Product Portfolio

    • Table Innovus Pharmaceuticals Company Details

    • Table Innovus Pharmaceuticals Over-The-Counter (OTC) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Innovus Pharmaceuticals Over-The-Counter (OTC) Drugs Main Business and Markets Served

    • Table Innovus Pharmaceuticals Over-The-Counter (OTC) Drugs Product Portfolio

    • Table Bayer Company Details

    • Table Bayer Over-The-Counter (OTC) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer Over-The-Counter (OTC) Drugs Main Business and Markets Served

    • Table Bayer Over-The-Counter (OTC) Drugs Product Portfolio

    • Table Cipla Company Details

    • Table Cipla Over-The-Counter (OTC) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cipla Over-The-Counter (OTC) Drugs Main Business and Markets Served

    • Table Cipla Over-The-Counter (OTC) Drugs Product Portfolio

    • Table Sanofi Company Details

    • Table Sanofi Over-The-Counter (OTC) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Over-The-Counter (OTC) Drugs Main Business and Markets Served

    • Table Sanofi Over-The-Counter (OTC) Drugs Product Portfolio

    • Figure Global Cold and Flu Products Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Analgesics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Dermatological Products Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Gastrointestinal Products Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Vitamin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Pharmacy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Retail Pharmacy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Online Pharmacy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Over-The-Counter (OTC) Drugs Consumption Forecast by Country (2022-2028)

    • Table North America Over-The-Counter (OTC) Drugs Consumption Forecast by Country (2022-2028)

    • Figure United States Over-The-Counter (OTC) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Over-The-Counter (OTC) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Over-The-Counter (OTC) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Over-The-Counter (OTC) Drugs Consumption Forecast by Country (2022-2028)

    • Figure Germany Over-The-Counter (OTC) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Over-The-Counter (OTC) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Over-The-Counter (OTC) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Over-The-Counter (OTC) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Over-The-Counter (OTC) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Over-The-Counter (OTC) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Over-The-Counter (OTC) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Over-The-Counter (OTC) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Over-The-Counter (OTC) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Over-The-Counter (OTC) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Over-The-Counter (OTC) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Over-The-Counter (OTC) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Over-The-Counter (OTC) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Over-The-Counter (OTC) Drugs Consumption Forecast by Country (2022-2028)

    • Figure China Over-The-Counter (OTC) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Over-The-Counter (OTC) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Over-The-Counter (OTC) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Over-The-Counter (OTC) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Over-The-Counter (OTC) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Over-The-Counter (OTC) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Over-The-Counter (OTC) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Over-The-Counter (OTC) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Over-The-Counter (OTC) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Over-The-Counter (OTC) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Over-The-Counter (OTC) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Over-The-Counter (OTC) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Over-The-Counter (OTC) Drugs Consumption Forecast by Country (2022-2028)

    • Figure Brazil Over-The-Counter (OTC) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Over-The-Counter (OTC) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Over-The-Counter (OTC) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Over-The-Counter (OTC) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Over-The-Counter (OTC) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Over-The-Counter (OTC) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Over-The-Counter (OTC) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Over-The-Counter (OTC) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Over-The-Counter (OTC) Drugs Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Over-The-Counter (OTC) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Over-The-Counter (OTC) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Over-The-Counter (OTC) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Over-The-Counter (OTC) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Over-The-Counter (OTC) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Over-The-Counter (OTC) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Over-The-Counter (OTC) Drugs Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Over-The-Counter (OTC) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Over-The-Counter (OTC) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Over-The-Counter (OTC) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Over-The-Counter (OTC) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Over-The-Counter (OTC) Drugs Consumption Forecast by Country (2022-2028)

    • Figure Australia Over-The-Counter (OTC) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Over-The-Counter (OTC) Drugs Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.